TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
PTCT

PTC Therapeutics Inc

Healthcare · Biotechnology

62.30$ -0.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement PTCT
Line item 2004 2005 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
1,535.2% 555.7% 72.7% -18.0% 175.2% 347.7% 331.3% 142.2% 2.4% 4.8% 4.0% 5.0% 6.0% 6.4% 7.0% 7.1% 4.1%
– – 100.0% 118.0% -75.2% -247.7% 100.0% 100.0% 97.6% 95.2% 96.0% 95.0% 94.0% 93.6% 93.0% 92.9% 95.9%
1,249.7% 425.3% 59.3% 160.3% 175.2% 347.7% 331.3% 142.2% 60.4% 65.0% 83.9% 125.4% 100.4% 93.2% 71.1% 66.2% 26.3%
– – 16.3% 50.8% 80.5% 195.2% 223.2% 117.4% 62.4% 58.0% 66.0% 64.4% 53.0% 42.9% 37.2% 37.3% 20.1%
– – 69.1% 193.2% 244.9% 532.9% 554.6% 259.7% 130.7% 131.6% 174.6% 208.4% 163.5% 157.6% 139.9% 130.4% 46.4%
– – 30.9% -93.2% -144.9% -432.9% -454.6% -159.7% -33.1% -43.7% -78.6% -113.4% -69.5% -64.0% -46.9% -37.5% 49.5%
0.0% 0.0% 2.5% 4.2% 19.4% 5.1% 6.4% 10.0% 6.2% 4.7% 4.1% 14.8% 16.0% 13.0% 13.8% 20.7% 8.8%
– – 28.9% -91.2% -164.6% -428.7% -462.3% -171.1% -40.0% -48.4% -78.2% -105.8% -96.2% -84.1% -74.2% -45.0% 40.3%
– – -2.3% 4.2% 19.8% -20.4% 1.3% 0.7% 0.7% 0.0% 3.8% 9.3% 1.0% -4.1% -7.4% 0.0% 0.8%
– – 31.2% -91.2% -164.6% -408.3% -463.6% -171.8% -40.6% -48.4% -82.0% -115.1% -97.3% -80.0% -66.8% -45.0% 39.4%
– – 33.8% -83.8% -137.3% -423.2% -446.8% -155.7% -24.0% -33.8% -63.6% -79.6% -68.4% -52.6% -35.2% -14.9% 51.3%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?